Chemsex Predicts STI Recurrence in MSM Using PrEP
New research showed higher rates of STIs and STI recurrence in MSM using PrEP who reported engaging in sexualized drug use, or “chemsex.”
Read More
HIV PrEP
Using Sex-Positive Campaigns to Disentangle PrEP Use From Promiscuity
Shahin Davoudpour, PhD, MA, MA, discusses the Keeping It LITE study and the use of sex-positive campaigns to disentangle PrEP use from promiscuity.
Read More
Internalized Homophobia Impacts PrEP Use in MSM
Among recently incarcerated men who have sex with men, PrEP use is impacted by internalized homophobia that is specifically related to sexual identity.
Read More
App Could Improve PrEP Uptake in People Who Inject Drugs
An app for HIV pre-exposure prophylaxis was acceptable to people who inject drugs and may offer a new strategy for increasing PrEP uptake in this population.
Read More
Digital PrEP Program Improves Access in LGBTQ+ Patients
An end-to-end digital PrEP pathway appeared to improve accessibility, inclusivity, and service satisfaction among LGBTQ+ patients, according to recent findings.
Read More
Peer Referrals Improve PrEP Uptake, Persistence & Adherence
Peer referrals for PrEP use among men who have sex with men improved PrEP uptake, persistence, and adherence at 6 months of study follow-up.
Read More
Mobile App Intervention Improves PrEP Uptake & HIV Testing
Researchers found that compared with standard care, the use of mobile apps increased PrEP uptake and HIV testing among young sexual minority men.
Read More
PrEP in Rural Areas: Integrating HIV Prevention & Harm Reduction
Utilizing syringe service programs to provide comprehensive PrEP care shows promise for encouraging more people who inject drugs to engage in HIV prevention.
Read More
Peer-Led HIV Prevention Strategies Promising for Latino MSM
Peer-led interventions for improving HIV prevention among Latino MSM exist, but research is needed before they can be fully implemented and used effectively.
Read More
Factors Identified for PrEP Initiation & Continuation in Homeless-Experienced PWUD
A low-threshold, harm reduction-oriented program for PrEP would support initiation and continuation for homeless-experienced people who use drugs.
Read More
Mutiple PrEP Choices Needed for MSM
Study results indicate the need for multiple care and formulation choices to improve PrEP uptake among men who have sex with men.
Read More
PrEP Use Doubles Over 3 Years, but Uneven Access Persists
Despite an improved HIV PrEP-to-need ratio from 2018 to 2021, PrEP use relative to need was lower in certain populations, including women and younger people.
Read More
PrEP Prescriptions Increase Among US Veterans
A recent study shows an increasing number of US veterans are being prescribed PrEP, similar to trends among persons with commercial or public health insurance.
Read More
Low PrEP Acceptance Common Among Women, Non-White Patients
Research shows particularly low PrEP acceptance among women and people of non-White origin, as well as low acceptance among individuals diagnosed with an STI.
Read More
Patient Empowerment, Rather than Access, Critical to Engage PWID in PrEP Care
Among people who inject drugs (PWID), decisions around PrEP are impeded by more pressing needs, and focusing on autonomy may help to engage PWID in PrEP uptake.
Read More
Addressing Clinician-Reported Barriers Improves Confidence in PrEP Prescribing
Clinician-reported barriers to PrEP prescribing include finances, perceptions about HIV risk, lack of training, and the amount of time required for PrEP care.
Read More
Steep Increase in Event-Driven PrEP Use
Researchers found a steep increase in even-driven PrEP use among cisgender gay, bisexual, and other men who have sex with men.
Read More
Considerable Scale-Up Needed to Meet 2025 HIV PrEP Goals
About 3.5 million persons used PrEP in 2023 globally, which was far below the goal of 21.2 million set for 2025.
Read More
Peer-to-Peer Outreach Increases PrEP Awareness in Underserved Groups
A peer-to-peer program successfully trained and mobilized volunteers to distribute information about PrEP to people not often included in outreach campaigns.
Read More
ICI Therapy Does Not Increase Mortality Risk in Patients With Pre-Existing Autoimmune Disease
The mortality risk in patients with pre-existing auto-immune disease is not significantly different from those without AIDS, in an immune checkpoint inhibitor study.
Read More- 1
- 2